Ran Frenkel Karyopharm Therapeutics Inc. (KPTI) insider trading activity

KPTI Quotes by TradingView

Ran Frenkel is EVP, Chief Dev. Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 168,290 shares of KPTI, which is worth approximately $127,900. The most recent transaction as insider was on Feb 28, 2022, when has been sold 1,663 shares (Common Stock) at a price of $10.24 per share, resulting in proceeds of $17,029. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 168K
0% 3M change
0% 12M change
Total Value Held $127,900

Ran Frenkel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2022
SELL
Open market or private sale
$17,029 $10.24 p/Share
1,663 Reduced 0.98%
168,290 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
68,250 Added 28.65%
169,953 Common Stock
Feb 17 2022
SELL
Open market or private sale
$35,499 $12.12 p/Share
2,929 Reduced 2.8%
101,703 Common Stock
Feb 07 2022
SELL
Open market or private sale
$19,631 $9.86 p/Share
1,991 Reduced 1.87%
104,632 Common Stock
Feb 25 2021
BUY
Grant, award, or other acquisition
-
22,013 Added 17.41%
104,439 Common Stock
Feb 18 2021
SELL
Open market or private sale
$42,814 $14.83 p/Share
2,887 Reduced 5.89%
46,126 Common Stock
Feb 15 2021
BUY
Exercise of conversion of derivative security
-
9,675 Added 16.49%
49,013 Common Stock
Feb 11 2021
SELL
Open market or private sale
$31,754 $15.52 p/Share
2,046 Reduced 4.94%
39,338 Common Stock
Feb 05 2021
BUY
Exercise of conversion of derivative security
-
5,650 Added 12.01%
41,384 Common Stock
RF

Ran Frenkel

EVP, Chief Dev. Officer
Newton, MA

Track Institutional and Insider Activities on KPTI

Follow Karyopharm Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

News

Receive news related to Karyopharm Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KPTI